DURHAM, N.C.--(BUSINESS WIRE)--For the second year in a row, PharPoint Research, Inc. is recognized as one of the 50 fastest growing private companies in the Raleigh-Durham area by the Triangle Business Journal. PharPoint was selected as a 2012 Fast 50 winner based on revenue growth and profitability in the previous three years (2009-2011).
PharPoint Research is a leading drug development service provider offering biotechnology and pharmaceutical companies expertise in project management, clinical monitoring, data management and biostatistics. The company is unique in its commitment to providing drug development services “the better way” through personalized attention, client responsiveness, and customized solutions.
“PharPoint’s continued success can be attributed to our employees who share in our commitment to quality and providing a level of customer service that encourages our clients to continue working with us,” commented Art Holmes, PharPoint’s President and CEO. “With high quality deliverables and exceptional customer service being our primary goals, we provide our clients with a flexible approach to drug development while meeting or exceeding the demands of the regulated drug development process.”
The official rankings of the honorees will be revealed at the Fast 50 Awards dinner on November 15th, 2012 at the Sheraton Imperial RTP at 6 p.m.
About PharPoint Research, Inc. - PharPoint Research, Inc. is a pharmaceutical development service provider specializing in clinical operations, data management and biostatistics. Our staff includes some of the most talented professionals in the industry, many of whom have working relationships that span over a decade. We pride ourselves on years of experience, superb repeat client rate, and the ability to consistently exceed the expectations of our clients. Founded in 2006, PharPoint currently has offices in Durham and Wilmington, NC. For more information about PharPoint Research, visit www.pharpoint.com or call 910.433.2440.